Studies in humans and cattle have also shown that CXCL9, also known as monokine induced by gamma interferon (MIG), has potential value as a biomarker for TB diagnosis and monitoring (Chung et al., 2015; Kumar et al., 2019; Palmer et al., 2020). This evidence concerns the gene IFNG and tuberculosis.